<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03111147</url>
  </required_header>
  <id_info>
    <org_study_id>2017-057</org_study_id>
    <nct_id>NCT03111147</nct_id>
  </id_info>
  <brief_title>Impact of Humeral Component Version on Outcomes Following RTSA</brief_title>
  <official_title>The Impact of Humeral Component Version on Outcomes Following Reverse Total Shoulder Arthroplasty: A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>William Beaumont Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>William Beaumont Hospitals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study is a prospective, single-blinded, randomized trial to investigate the&#xD;
      impact of humeral component version on shoulder range of motion and patient reported&#xD;
      functional outcomes following reverse total shoulder arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective clinical evidence suggests that increasing humeral component retroversion does&#xD;
      not affect measured internal or external rotation, however patients with neutral version may&#xD;
      experience better function with daily activities requiring internal rotation compared to&#xD;
      those with 30 degrees of retroversion. Prospective data on clinical outcomes comparing&#xD;
      different humeral component versions in RTSA is currently lacking. The proposed study is a&#xD;
      prospective, single-blinded, randomized trial to investigate the impact of humeral component&#xD;
      version on shoulder range of motion and patient reported functional outcomes following&#xD;
      reverse total shoulder arthroplasty.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 12, 2017</start_date>
  <completion_date type="Anticipated">May 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative ROM</measure>
    <time_frame>2 years</time_frame>
    <description>External and internal range of motion measurements of the shoulder</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">85</enrollment>
  <condition>Rotator Cuff Tear Arthropathy</condition>
  <arm_group>
    <arm_group_label>0 degrees humeral component version</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reverse Total Shoulder Arthroplasty with humeral component positioned in 0 degrees of version</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30 degrees humeral component retroversion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reverse Total Shoulder Arthroplasty with humeral component positioned in 30 degrees of retroversion</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>0 degrees humeral component version</intervention_name>
    <description>RTSA with humeral component positioned in 0 degrees of version</description>
    <arm_group_label>0 degrees humeral component version</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>30 degrees humeral component retroversion</intervention_name>
    <description>RTSA with humeral component positioned in 30 degrees of retroversion</description>
    <arm_group_label>30 degrees humeral component retroversion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing primary reverse total shoulder arthroplasty&#xD;
&#xD;
          -  Diagnosis of cuff tear arthropathy or primary OA with RCT&#xD;
&#xD;
          -  Intact posterior rotator cuff and subscapularis preoperatively, as determined by&#xD;
             surgeon-administered physical exam&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Revision arthroplasty&#xD;
&#xD;
          -  Diagnosis of rheumatoid arthritis, infection, acute trauma or instability&#xD;
&#xD;
          -  Minors (under 18 years of age)&#xD;
&#xD;
               -  Prior open shoulder surgery&#xD;
&#xD;
               -  Concomitant latissimus dorsi transfer&#xD;
&#xD;
               -  Patients not undergoing a standard of care physical therapy protocol&#xD;
&#xD;
               -  Pregnant, patient-reported&#xD;
&#xD;
               -  Cognitively impaired&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Michael Wiater, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>William Beaumont Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beaumont Health</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>William Beaumont Hospitals</investigator_affiliation>
    <investigator_full_name>Michael Wiater</investigator_full_name>
    <investigator_title>◾Vice Chairman Orthopedic Surgery◾Chief of Shoulder Surgery ◾Program Director, Fellowship in Shoulder and Elbow Surgery ◾Program Director, Orthopaedic Surgery Residency</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Rotator Cuff Tear Arthropathy</mesh_term>
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

